Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
4 pending office actions • 3 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Fundação Oswaldo Cruz has 4 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are distributed among 4 distinct examiners and 3 distinct art units, indicating a mix of technical focuses. The use of 3 distinct art units suggests that the foundation's biotechnological or pharmaceutical research is being evaluated by several different specialized groups within the patent office. This distribution means the foundation must navigate the requirements of 3 distinct art units, each with its own set of examination standards and timelines.
HINES, JANA A is the busiest examiner for the portfolio, currently managing 1 pending office action. With 4 pending office actions in total and 4 distinct examiners involved, the workload is spread such that each examiner is responsible for exactly one matter. This lack of examiner concentration means that prosecution strategies must be tailored to the specific tendencies of four different individuals. The presence of 4 distinct examiners across 3 distinct art units highlights the need for a versatile approach to the foundation's Biotechnology & Pharmaceuticals portfolio.
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (25%) |
| §102 only | 1 (25%) |
| §112 only | 1 (25%) |
| Multi-statute (no §101) | 1 (25%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HINES, JANA A | 1 | 53.2% | +39.4% |
| DEVI, SARVAMANGALA | 1 | 65.5% | +55.5% |
| WANG, CHANG YU | 1 | 33.4% | +53.7% |
| YIP, JACK | 1 | 33.1% | +37.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18574262 | Veterinary Vaccine Composition Against Parasitic Worms, Method for Treating and Preventing Infection by Parasitic Worms, and Use | HINES, JANA A | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17794646 | RAT BIOMODELS FOR TRAINING IN MEDICAL CRANIOTOMY TECHNIQUES | YIP, JACK | 23d overdue |
| 18564843 | RECOMBINANT CHIMERIC PROTEIN, USE THEREOF, AND COMPOSITION | DEVI, SARVAMANGALA | 12d |
| 18021566 | PROTEIN, POLYNUCLEOTIDE, VECTOR, HOST CELL, COMPOSITION, METHOD FOR TREATING AN ILLNESS, IN-VITRO METHOD FOR PREDICTING MULTIPLE SCLEROSIS, AND USE OF A PROTEIN OR COMPOSITION | WANG, CHANG YU | 12d |
| 18574262 | Veterinary Vaccine Composition Against Parasitic Worms, Method for Treating and Preventing Infection by Parasitic Worms, and Use | HINES, JANA A | — |
| Art Unit | Apps |
|---|---|
| 1645 | 2 |
| 1675 | 1 |
| 3715 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18574262 | Veterinary Vaccine Composition Against Parasitic Worms, Method for Treating and Preventing Infection by Parasitic Worms, and Use | HINES, JANA A | 1645 | §103§112 | Final Rejection | — | Pending | Dec 26, 2023 |
| 18564843 | RECOMBINANT CHIMERIC PROTEIN, USE THEREOF, AND COMPOSITION | DEVI, SARVAMANGALA | 1645 | §112 | Final Rejection | 12d | Pending | Nov 28, 2023 |
| 18021566 | PROTEIN, POLYNUCLEOTIDE, VECTOR, HOST CELL, COMPOSITION, METHOD FOR TREATING AN ILLNESS, IN-VITRO METHOD FOR PREDICTING MULTIPLE SCLEROSIS, AND USE OF A PROTEIN OR COMPOSITION | WANG, CHANG YU | 1675 | §102 | Final Rejection | 12d | Pending | Feb 16, 2023 |
| 17794646 | RAT BIOMODELS FOR TRAINING IN MEDICAL CRANIOTOMY TECHNIQUES | YIP, JACK | 3715 | §103 | Non-Final OA | 23d overdue | Pending | Jul 22, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialFundação Oswaldo Cruz has 4 pending office actions as of October 2026, spread across 3 art units and 4 examiners.
Jana A Hines has the most, with 1 of Fundação Oswaldo Cruz's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
